Emergent BioSolutions, Inc. (EBS)
5.89
0.00 (0.00%)
USD |
NYSE |
Nov 13, 10:40
Emergent BioSolutions Net Income (Annual) : 52.60M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 52.60M |
| December 31, 2024 | -190.60M |
| December 31, 2023 | -760.50M |
| December 31, 2022 | -211.60M |
| December 31, 2021 | 219.50M |
| December 31, 2020 | 305.10M |
| December 31, 2019 | 54.50M |
| December 31, 2018 | 62.70M |
| December 31, 2017 | 82.60M |
| December 31, 2016 | 62.52M |
| December 31, 2015 | 91.42M |
| December 31, 2014 | 36.74M |
| Date | Value |
|---|---|
| December 31, 2013 | 30.26M |
| December 31, 2012 | 18.14M |
| December 31, 2011 | 16.11M |
| December 31, 2010 | 47.18M |
| December 31, 2009 | 26.54M |
| December 31, 2008 | 19.96M |
| December 31, 2007 | 22.94M |
| December 31, 2006 | 22.79M |
| December 31, 2005 | 15.78M |
| December 31, 2004 | 11.47M |
| December 31, 2003 | 4.454M |
| December 31, 2002 | 36.39M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Arcturus Therapeutics Holdings, Inc. | -65.78M |
| Capricor Therapeutics, Inc. | -105.04M |
| Travere Therapeutics, Inc. | -50.26M |
| Syndax Pharmaceuticals, Inc. | -285.42M |